Verastem Shares Rise 5% On Strong AVMAPKI Sales Update

Core Insights - Verastem, Inc. (VSTM) shares increased by 4.60 percent, or $0.29, reaching $6.59 following the announcement of preliminary fourth-quarter results [1] - The company reported net product revenue of approximately $17.5 million for Q4 2025 and full-year revenue of about $30.9 million for AVMAPKI FAKZYNJA CO-PACK [1] - Verastem emphasized a strong cash position that extends its financial runway into the first half of 2027 [1] Stock Performance - The stock opened at $6.42, compared to a previous close of $6.30, and traded within a range of $6.42 to $7.00 on the New York Stock Exchange [2] - The last bid was $4.96, while the ask was $8.30, with a trading volume of approximately 2,734,477 shares, exceeding the average volume of 2,006,367 [2] - Verastem's 52-week stock price range is between $4.01 and $11.25 [2]